Antibiotic-resistance continues to be a challenge for the healthcare industry, as medical and public health professionals look for ways to combat it even as more multiple-drug resistant (MDR) bacteria, viruses, and fungi emerge. Affordable genetic testing is a relatively new option for battling MDRs, offering ways to improve testing and practices for antibiotic stewardship. Talk of stewardship programs can sometimes devolve into buzzwords, notes Dr. Joel Diamond, CMO of Aranscia. Competing interests, litigation, and varying pressures can make locking down a true stewardship mindset difficult.
